| Patient | Fyodor Dostoevsky |
|---|---|
| Date of birth | 1821-11-11 |
| Identifiers | MRN HR-NI018-SYN-TD; SSN (made up) 000-18-3907 |
| Document date | 2026-11-01 |
| Author | Agnes Lindahl, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care after recurrent seizures: seizure history, baseline tests, EEG and MRI orders, seizure safety, and gambling-disorder assessment with a safety assessment. Concerns: He wants the seizures to stop interrupting his writing and his deadlines; He wants to stop losing money at roulette and to pay off his debts. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Lamotrigine 25 mg tablets, slow titration: 25 mg once daily for weeks 1 and 2, 50 mg once daily for weeks 3 and 4, 50 mg twice daily for week 5, and 75 mg twice daily for week 6 | 25 mg once daily, increased every two weeks and then weekly as written, to 75 mg twice daily in week 6 | Oral route | 1865-03-03 to 1865-04-13 | completed | S |
| Lamotrigine 100 mg tablet, one tablet twice daily | 100 mg twice daily (200 mg a day), 30-day supply at a time | Oral route | 1865-04-14 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Routine EEG with photic stimulation and hyperventilation: normal background, no epileptiform discharges | 1865-02-17 to 1865-02-17 | completed | S |
| MRI of the brain, epilepsy protocol: normal, with no hippocampal sclerosis, cortical malformation, or other lesion | 1865-02-20 to 1865-02-20 | completed | S |
| Sleep-deprived EEG: normal, with no epileptiform discharges in wakefulness or sleep | 1865-03-24 to 1865-03-24 | completed | S |
| Advance care planning conversation, about 20 minutes | 1865-10-20 to 1865-10-20 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1860-05-12 | Tetanus, diphtheria, and pertussis (Tdap) booster | completed | S |
| 1865-10-20 | Influenza vaccine, 1865-1866 season | completed | S |
| 1865-10-20 | Hepatitis B vaccine (HepB-CpG), dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1849 | Epilepsy since early adulthood, with recurrent seizures; the timing of onset and diagnosis differs between accounts | R (CLM-0003) |
| 1853 | Seizures worsened during four years of forced labor in the prison at Omsk | D (CLM-0004) |
| 1863 | Sought expert advice on his epilepsy from neurologists abroad | D (CLM-0002) |
| 1863 | Compulsive roulette gambling with losses and pawned belongings, beginning on a tour of Europe | D (CLM-0009) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He wants the seizures to stop interrupting his writing and his deadlines | active | S |
| He wants to stop losing money at roulette and to pay off his debts | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 14.6 on 1865-02-03; Leukocytes [#/volume] in Blood by Automated count 6.8 on 1865-02-03; Platelets [#/volume] in Blood by Automated count 248 on 1865-02-03; Sodium [Moles/volume] in Serum or Plasma 137 on 1865-06-09; Potassium [Moles/volume] in Serum or Plasma 3.6 on 1865-06-09; Creatinine [Mass/volume] in Serum or Plasma 1.08 on 1865-06-09; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1860)/1.73 sq M 98 on 1865-02-03; Glucose [Mass/volume] in Serum or Plasma 84 on 1865-06-09; Calcium [Mass/volume] in Serum or Plasma 9.5 on 1865-02-03; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 1865-02-03; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 1865-02-03; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 32 on 1865-02-03; Hemoglobin A1c/Hemoglobin.total in Blood 5.3 on 1865-02-03; Cholesterol [Mass/volume] in Serum or Plasma 182 on 1865-02-03; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 1865-02-03; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 108 on 1865-02-03; Triglyceride [Mass/volume] in Serum or Plasma 110 on 1865-02-03; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 on 1865-10-06; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 8 on 1865-10-06; Total score [AUDIT-C] 2 on 1865-10-20; lamoTRIgine [Mass/volume] in Serum or Plasma 5.9 on 1865-10-06; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 1865-10-20 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Epilepsy of unknown type with recurrent generalized tonic-clonic seizures of unknown onset, untreated for many years; etiology unknown | active | confirmed | G40.909 | S — Synthetic modern coding of his documented epilepsy. The seizure type is left as unknown onset under the ILAE classification, because the retrospective classifications are disputed; no focal or generalized syndrome is coded. |
| Gambling disorder (roulette, in person and online), moderate, with debts | active | confirmed | F63.0 | S — Synthetic modern coding of his documented compulsive roulette gambling. |
| Acute viral gastroenteritis with vomiting and two missed lamotrigine doses, without dehydration needing intravenous fluids; resolved | resolved | confirmed | A08.4 | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach missed antiseizure doses during vomiting; it does not echo a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1865-02-03 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1865-02-03 | Leukocytes [#/volume] in Blood by Automated count | 6.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1865-02-03 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1865-02-03 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1865-02-03 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1865-02-03 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1865-02-03 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1860)/1.73 sq M | 98 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1865-02-03 | Glucose [Mass/volume] in Serum or Plasma | 88 | mg/dL | 70-99 mg/dL | Normal | S |
| 1865-02-03 | Calcium [Mass/volume] in Serum or Plasma | 9.5 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1865-02-03 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-56 U/L | Normal | S |
| 1865-02-03 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 10-40 U/L | Normal | S |
| 1865-02-03 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 32 | ng/mL | 30-100 ng/mL | Normal | S |
| 1865-02-03 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.3 | % | <=5.6% | Normal | S |
| 1865-02-03 | Cholesterol [Mass/volume] in Serum or Plasma | 182 | mg/dL | <=200 mg/dL | Normal | S |
| 1865-02-03 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 1865-02-03 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 108 | mg/dL | <=129 mg/dL | Normal | S |
| 1865-02-03 | Triglyceride [Mass/volume] in Serum or Plasma | 110 | mg/dL | <=149 mg/dL | Normal | S |
| 1865-02-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 1865-02-03 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | {score} | S | ||
| 1865-02-03 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 1865-05-05 | lamoTRIgine [Mass/volume] in Serum or Plasma | 6.2 | ug/mL | 2.5-15 ug/mL | Normal | S |
| 1865-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1865-07-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 1865-10-06 | lamoTRIgine [Mass/volume] in Serum or Plasma | 5.9 | ug/mL | 2.5-15 ug/mL | Normal | S |
| 1865-10-06 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S | ||
| 1865-10-06 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S | ||
| 1865-06-09 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1865-06-09 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1865-06-09 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1865-06-09 | Glucose [Mass/volume] in Serum or Plasma | 84 | mg/dL | 70-99 mg/dL | Normal | S |
| 1865-10-20 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1865-10-20 | Total score [AUDIT-C] | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1865-02-03 | Body height | 170 | cm | S |
| 1865-02-03 | Body weight | 68 | kg | S |
| 1865-02-03 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1865-02-03 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1865-02-03 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1865-02-03 | Heart rate | 74 | /min | S |
| 1865-02-03 | Respiratory rate | 14 | /min | S |
| 1865-02-03 | Body temperature | 36.7 | Cel | S |
| 1865-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1865-03-03 | Body height | 170 | cm | S |
| 1865-03-03 | Body weight | 68.4 | kg | S |
| 1865-03-03 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 1865-03-03 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1865-03-03 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1865-03-03 | Heart rate | 72 | /min | S |
| 1865-03-03 | Respiratory rate | 14 | /min | S |
| 1865-03-03 | Body temperature | 36.6 | Cel | S |
| 1865-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1865-05-05 | Body height | 170 | cm | S |
| 1865-05-05 | Body weight | 68.8 | kg | S |
| 1865-05-05 | Body mass index (BMI) [Ratio] | 23.8 | kg/m2 | S |
| 1865-05-05 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1865-05-05 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1865-05-05 | Heart rate | 70 | /min | S |
| 1865-05-05 | Respiratory rate | 14 | /min | S |
| 1865-05-05 | Body temperature | 36.7 | Cel | S |
| 1865-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1865-07-07 | Body height | 170 | cm | S |
| 1865-07-07 | Body weight | 68.6 | kg | S |
| 1865-07-07 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 1865-07-07 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1865-07-07 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1865-07-07 | Heart rate | 70 | /min | S |
| 1865-07-07 | Respiratory rate | 14 | /min | S |
| 1865-07-07 | Body temperature | 36.6 | Cel | S |
| 1865-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1865-10-06 | Body height | 170 | cm | S |
| 1865-10-06 | Body weight | 68 | kg | S |
| 1865-10-06 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1865-10-06 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1865-10-06 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1865-10-06 | Heart rate | 78 | /min | S |
| 1865-10-06 | Respiratory rate | 14 | /min | S |
| 1865-10-06 | Body temperature | 36.7 | Cel | S |
| 1865-10-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1865-06-09 | Body height | 170 | cm | S |
| 1865-06-09 | Body weight | 67.2 | kg | S |
| 1865-06-09 | Body mass index (BMI) [Ratio] | 23.3 | kg/m2 | S |
| 1865-06-09 | Systolic blood pressure | 112 | mm[Hg] | S |
| 1865-06-09 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1865-06-09 | Heart rate | 96 | /min | S |
| 1865-06-09 | Respiratory rate | 16 | /min | S |
| 1865-06-09 | Body temperature | 37.6 | Cel | S |
| 1865-06-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1865-10-20 | Body height | 170 | cm | S |
| 1865-10-20 | Body weight | 68.2 | kg | S |
| 1865-10-20 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 1865-10-20 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1865-10-20 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1865-10-20 | Heart rate | 72 | /min | S |
| 1865-10-20 | Respiratory rate | 14 | /min | S |
| 1865-10-20 | Body temperature | 36.6 | Cel | S |
| 1865-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1865-02-03 | Establishing care after recurrent seizures: seizure history, baseline tests, EEG and MRI orders, seizure safety, and gambling-disorder assessment with a safety assessment | finished | S |
| 1865-03-03 | Four-week follow-up with neurology consultation; EEG and MRI reviewed and lamotrigine started | finished | S |
| 1865-05-05 | Two-month review: lamotrigine at maintenance dose, rash and mood check, and gambling treatment progress | finished | S |
| 1865-07-07 | Four-month review of seizure control, mood, and gambling recovery | finished | S |
| 1865-10-06 | Eight-month review after a breakthrough seizure and a gambling lapse while traveling | finished | S |
| 1865-06-09 | Same-day sick visit for vomiting and diarrhea with missed lamotrigine doses | finished | S |
| 1865-10-20 | Adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Neurology consultation for seizure classification, EEG and MRI review, and the choice of antiseizure medicine | completed | GL-AAN-FIRSTSZ-2015, GL-ILAE-SZ-2017, GL-ILAE-EPI-2017 | S |
| Antiseizure medicine: lamotrigine with slow titration, rash teaching, 30-day supplies, a pill organizer and phone alarms, a seizure diary, and levels only when they would change care | completed | GL-AAN-NEWASM-2018, GL-SANAD2-2021 | S |
| Seizure safety at every visit: triggers (sleep loss, alcohol, overwork), showers rather than baths, no swimming or heights alone, no driving until seizure-free and cleared by his neurologist, a written seizure action plan for friends, and a SUDEP discussion | completed | GL-AAN-SUDEP-2017, GL-AAN-FIRSTSZ-2015 | S |
| Gambling-disorder treatment: cognitive behavioral therapy with a gambling-disorder therapist, self-exclusion, a bank gambling block, Gamblers Anonymous, and free debt counseling | completed | GL-GAMB-COCHRANE-2012, GL-GAMB-NRDP-2019 | S |
| Mood and safety: PHQ-9 at intake and every two to four months, GAD-7 at intake and with any change, and a suicide-risk review with the 988 Suicide & Crisis Lifeline at every visit | completed | GL-CMID-2026, GL-ILAE-DEP-2022, GL-SUICIDE-2024 | S |
| Bone health: baseline vitamin D; lamotrigine is not an enzyme inducer, so no DXA scan is needed unless an enzyme-inducing medicine is added | completed | GL-AAN-NEWASM-2018 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Reach the lamotrigine maintenance dose without rash by the two-month visit | 1865-05-05 | completed | Maintenance dose of 100 mg twice daily reached after six weeks; no rash | S |
| No seizures for six months after reaching the maintenance dose | 1865-10-06 | active | Not met: one generalized tonic-clonic seizure about five months after reaching the maintenance dose, after missed doses and a night without sleep; the six-month count restarts | S |
| Casino and online self-exclusion and a bank gambling block in place by the four-week visit | 1865-03-03 | completed | Self-exclusion from casinos in the state and from licensed online sites, and a gambling block on his bank cards, in place | S |
| No gambling through the eight-month visit | 1865-10-06 | active | Not met: no gambling for about seven months, then a lapse while traveling abroad, outside the reach of his self-exclusion; treatment intensified | S |
| Written seizure action plan, safety counseling, and a SUDEP discussion completed by the four-week visit | 1865-03-03 | completed | Plan written and shared with two friends; SUDEP discussed with the neurologist | S |
Structured synthetic safety assessment on 1865-02-03: current ideation absent, intent absent, plan absent. Routine outpatient care. Gambling disorder carries a raised suicide risk, especially after large losses, so safety is reviewed at every visit. He saved the 988 Suicide & Crisis Lifeline and the National Problem Gambling Helpline in his phone and agreed to call either after a large loss or if hopeless thoughts appear. Antiseizure medicine is dispensed as a 30-day supply [S]